{
    "nctId": "NCT02494037",
    "briefTitle": "The Canadian/US Integrative Oncology Study",
    "officialTitle": "The Canadian/US Integrative Oncology Study (CUSIOS): Advanced Integrative Oncology Treatment for Patients With Advanced Stage Cancer: A Prospective Outcomes Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Colorectal Neoplasms, Pancreatic Neoplasms, Ovarian Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 400,
    "primaryOutcomeMeasure": "Survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* A new patient coming in for a first office call (FOC) with a participating site investigator for their cancer or a current patient whose FOC with a participating investigator for their cancer was after study start date of January 1, 2015\n* \u226518 years of age\n* Able to understand study design and provide signed informed consent to enrollment\n* Confirmed diagnosis of one of the following cancers: stage 4/metastatic breast, stage 4/metastatic colorectal, stage 3 or 4/metasatic ovarian, or stage 3 or 4/metastatic pancreatic\n* Canadian participants with a visit \\<3 months post-FOC are eligible for the HRQOL sub-study\n* Participants must be governed by the laws of the country within which they are receiving AIO care\n\nExclusion Criteria:\n\n* None",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}